Biotech Startups

Laurent Pharmaceuticals is a clinical-stage pharmaceutical company focused on drug development. It works on therapeutic candidates through clinical development programs.

1 investor

Laurus Bio, a subsidiary of Laurus Labs, is a biomanufacturing company using precision fermentation and recombinant DNA technology to produce animal-origin-free recombinant proteins, growth factors, and cell-culture media supplements. It serves the biopharma, cultured meat, and cell-culture markets and offers CDMO precision fermentation services to protein companies and bio-manufacturers across healthcare, food, nutrition, personal care, and bio-based materials.

1 investor

Laurus Labs is a pharmaceutical company that manufactures active pharmaceutical ingredients (APIs) and runs R&D and biotech operations, including a Laurus Bio unit. It operates FDA-audited API manufacturing facilities and is a publicly listed company reporting quarterly financial results.

1 investor

LeafWorks conducts plant genomics research linking genotypes to agriculturally and commercially relevant traits, and develops DNA-based tests and services for genetic identification of botanical species. It serves clients in the natural products industry, offering services that support risk mitigation, supply-chain transparency, and modern plant breeding.

1 investor

Leal Therapeutics is a company focused on CNS (central nervous system) disorders, drawing on academic and drug-development experience in neurology and neurodegenerative disease.

1 investor

Oncology company developing targeted and immuno-oncology therapeutics; lead candidate DKN-01 targets the DKK1 protein.

1 investor

Leapfrog Bio is an oncology therapeutics company that uses its Precision PGx Platform to identify and develop targeted cancer treatments, focusing on patients with loss-of-function mutations through synthetic lethality and pharmacogenomic screening.

1 investor

Leap Therapeutics develops targeted and immunotherapy-based cancer treatments, including monoclonal antibodies in clinical development for esophagogastric, gynecologic, colorectal, gastric, and pancreatic cancers.

1 investor

Leash Bio is a biotech company developing AI-driven drug discovery tools, combining molecular chemistry expertise with machine learning to accelerate research workflows for pharma and biotech organizations.

1 investor

Legacy Health Strategies partners with pharmaceutical and medical device companies to incorporate patient perspectives into product development and clinical trials. The company serves the biopharma and healthcare industries, specializing in patient and community engagement, clinical trial transparency, and patient-centered innovation.

1 investor

Leica Microsystems manufactures optical microscopy instruments and fluorescence reagents for scientific research and diagnostics. The company serves laboratories, research institutions, and diagnostic facilities requiring advanced imaging and analytical equipment.

1 investor

Leinco Technologies manufactures antibodies and proteins, offering both large- and small-scale IVD antibody and protein production along with CDMO services for scientists in life sciences discovery, biopharmaceutical, and diagnostics segments. Its reagents support research in areas such as cancer, infectious diseases, and immunology.

1 investor

Lembas develops science-backed functional ingredients and supplements for weight management, designed to support fullness and metabolic health. It partners with supplement, food, beverage, and wellness brands to incorporate its clean-label ingredients into bars, shakes, snacks, and boosters.

1 investor

Lemna Bio develops computational biology and deep learning tools to predict and explain biomolecular interactions. The company targets researchers and partners working on molecular discovery problems across life sciences.

1 investor

Lemna Labs develops natural active and functional ingredients derived from duckweed for use in cosmetic and personal care formulations. The company focuses on plant-based innovation combining efficacy, sustainability, and supply chain independence.

1 investor

Lemnisca Bio builds AI-native digital twins ("flight simulators") that model bioprocess behavior using machine learning combined with metabolic and reactor physics rules, helping make precision fermentation and biomanufacturing predictable and scalable. The platform supports R&D recipe discovery, scale-up guidance, and real-time manufacturing control for bioprocess and biotech producers.

1 investor

1 investor

LenioBio develops ALiCE, a cell-free protein expression platform that accelerates the discovery, development, and manufacturing of proteins and biologics for pharmaceutical and vaccine manufacturers. The platform addresses production bottlenecks in drug and vaccine development by enabling faster, scalable biomanufacturing beyond traditional cell-based approaches.

1 investor

LensGen is an ophthalmic medical device company that has developed Juvene, a curvature-changing fluid-optic intraocular lens designed to treat cataracts and presbyopia. The biomimetic lens is placed in the position of the eye's natural lens and adjusts its dioptric power using the eye's own muscle contractions.

1 investor

LeonaBio develops novel therapeutics for treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS). The company targets patients with diseases that have significant unmet medical needs.

1 investor

Leucid Bio develops CAR-T cell therapies based on a proprietary Lateral CAR platform that redesigns the CAR structure to mimic the lateral signalling arrangement of natural immune receptors. The technology, derived from 20 years of research led by Dr John Maher at King's College London, aims to increase T-cell potency and durability while reducing toxicity.

1 investor

Leucine provides an AI-powered integrated platform for pharmaceutical manufacturing operations, combining manufacturing execution systems (MES), quality management systems (QMS), and laboratory execution systems (LES) to optimize batch production, ensure regulatory compliance, and automate documentation workflows.

1 investor

Leucine offers AI Investigator, a quality management platform that automates root cause analysis and provides data-driven corrective action recommendations for manufacturing and quality assurance teams.

1 investor

Lever VC is a venture capital firm focused on alternative protein and sustainable food and agriculture. The firm's investment team has deployed over $500 million and executed over 100 deals since 2014, backed by in-house scientific and technical expertise in bioengineering, materials science, and synthetic biology.

1 investor